表紙:組み換え細胞培養サプリメント市場-世界の産業規模、シェア、動向、機会、予測、2018-2028年、、製品別、用途別、発現系別、エンドユーザー別、地域別、競合
市場調査レポート
商品コード
1266842

組み換え細胞培養サプリメント市場-世界の産業規模、シェア、動向、機会、予測、2018-2028年、、製品別、用途別、発現系別、エンドユーザー別、地域別、競合

Recombinant Cell Culture Supplements Market- Global Industry Size, Share, Trends, Opportunity and Forecast, 2018-2028F, By Product, By Application, By Expression System, By End User, By Region and Competition

出版日: | 発行: TechSci Research | ページ情報: 英文 266 Pages | 納期: 2~3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=154.36円

こちらのレポートには、数時間(ご購入金額の10%)分のアナリストへの質問/追加調査サービスが含まれております。

組み換え細胞培養サプリメント市場-世界の産業規模、シェア、動向、機会、予測、2018-2028年、、製品別、用途別、発現系別、エンドユーザー別、地域別、競合
出版日: 2023年04月01日
発行: TechSci Research
ページ情報: 英文 266 Pages
納期: 2~3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

組み換え細胞培養サプリメント市場は、2022年に4億7,276万米ドルとなり、さらに生物学的製剤の需要増加により、予測期間中に8.99%のCAGRで成長すると予測されています。

組換え細胞培養サプリメント市場は、細胞培養技術の進歩やバイオ医薬品研究への投資の増加などの要因によって、今後数年間は成長を続けると予想されます。

個別化医療の発展

個別化医療の開拓が組換え細胞培養補助食品市場の成長に影響を与えています。個別化医療では、個々の患者の特定のニーズに合わせて治療法を調整します。このアプローチでは、遺伝子療法や細胞療法などの個別化治療薬の開発・生産が必要となります。これらの治療法には、細胞の成長と生産性を最適化するために使用される、特殊な細胞培養サプリメントが必要です。

ヒトゲノムの研究であるゲノミクスの進歩により、科学者は病気の遺伝的基盤についてより深く理解することができるようになりました。この知識は、患者さんの遺伝子プロファイルに合わせてカスタマイズできる標的治療の開発につながっています。例えば、がん治療の中には、患者さんの腫瘍の特定の遺伝子変異に合わせた治療が行われるようになり、より良い治療成績と副作用の軽減につながります。

医療費の高騰が続く中、より効果的で効率的なヘルスケアを求める声が高まっています。個別化医療のアプローチは、より的を絞った効果的な治療の可能性を提供し、長期的にはより良い転帰と医療費の削減につながる可能性があります。規制環境もまた、個別化医療の発展に影響を与える可能性があります。近年、規制当局は個別化医療アプローチの開発と承認に重点を置いており、この分野への投資の増加につながっています。

また、個別化医療の発展は、技術の進歩によっても促進されています。次世代シーケンサーやCRISPR遺伝子編集などの新しい診断ツールにより、科学者は病気の遺伝的基盤の理解を深め、標的療法を開発することができるようになっています。また、データ解析の進歩により、研究者は大量のゲノムデータや臨床データを解析してパターンを特定し、新たな治療法を開発することができるようになっています。

個別化医療の動向は拡大しており、これが組換え細胞培養用サプリメントの需要を牽引しています。その結果、組換え細胞培養サプリメント市場は今後も成長を続けると予想され、市場にイノベーションと成長の機会を提供しています。

慢性疾患の有病率の上昇

慢性疾患の有病率の上昇が組換え細胞培養補助食品市場の成長に影響を与えています。がん、糖尿病、心血管疾患などの慢性疾患は、世界的に死亡原因の上位を占めており、これらの疾患を治療するための生物学的薬剤の需要が高まっています。生物学的製剤は培養した生きた細胞を用いて製造されるため、細胞の成長と生産性を最適化するために組換え細胞培養サプリメントを使用する必要があります。公害、毒物への曝露、感染症などの環境要因も、慢性疾患の発症の一因となり得ます。大気汚染への曝露は呼吸器系および循環器系疾患の発症に、鉛やアスベストなどの有害物質への曝露はがんの発症に、それぞれ関連しています。また、遺伝的な要因も慢性疾患の発症に関与することがあり、遺伝的な要素を持つ疾患もあります。遺伝子検査や個別化医療のアプローチは、特定の慢性疾患の発症リスクが高い人々を特定するのに役立ちます。

より多くの患者が革新的で効果的な治療法を求めているため、慢性疾患の有病率の上昇が組換え細胞培養市場の成長を後押ししています。さらに、人口の高齢化もこの市場の成長に寄与しています。高齢化に伴い、慢性疾患を発症する可能性が高くなるため、新しい革新的な治療法に対する需要が高まっています。

慢性疾患の有病率が上昇し続ける中、生物学的製剤や組換え細胞培養用サプリメントの需要も高まっています。この傾向は今後も続くと予想され、市場に革新と成長の機会をもたらしています。

利用可能なカスタマイズ

与えられた市場データをもとに、TechSci Researchは企業の特定のニーズに応じてカスタマイズを提供します。本レポートでは、以下のカスタマイズが可能です:

会社情報

  • 追加市場プレイヤー(最大5社)の詳細分析およびプロファイリング

目次

第1章 概要

  • 市場の定義
  • 市場の範囲
    • 対象市場
    • 研究対象年
    • 主な市場セグメンテーション

第2章 調査手法

  • 調査目的
  • ベースライン調査手法
  • 主要産業パートナー
  • 主な協会と二次情報
  • 調査手法
  • データの三角測量と検証
  • 前提条件と限界

第3章 エグゼクティブサマリー

  • 市場概要
  • 主要市場セグメンテーションの概要
  • 主要市場プレイヤーの概要
  • 主要地域/国の概要
  • 市場促進要因・課題・動向

第4章 VOC (顧客の声)

第5章 組み換え細胞培養サプリメントの世界市場展望

  • 市場規模・予測
    • 金額別
  • 市場シェアと予測
    • 製品別(遺伝子組換えインスリン、遺伝子組換え上皮成長因子、遺伝子組換えアルブミン、遺伝子組換えコラーゲン、遺伝子組換えトランスフェリン、遺伝子組換えトリプシン、その他)
    • アプリケーション別(再生医療vsバイオプロダクション)
    • 再生医療(幹細胞治療、細胞治療、遺伝子治療)により
    • バイオプロダクション別(モノクローナル抗体、遺伝子組換えタンパク質、ホルモン、ワクチン、その他)
    • 発現系別(哺乳類発現系、大腸菌発現系、酵母発現系、その他)
    • エンドユーザー別(学術・調査機関、バイオテクノロジー・製薬会社)
    • 企業別(2022年)
    • 地域別
  • マーケットマップ
    • 製品別
    • アプリケーション別
    • 再生医療別
    • バイオプロダクション別
    • エクスプレッション・システム別
    • エンドユーザー別
    • 地域別

第6章 北米の組み換え細胞培養サプリメント市場の展望

  • 市場規模・予測
    • 金額別
  • 市場シェアと予測
    • 製品別
    • アプリケーション別
    • 再生医療別
    • バイオプロダクション別
    • エクスプレッション・システム別
    • エンドユーザー別
    • 国別
  • 北米の場合:国別分析
    • 米国
    • メキシコ
    • カナダ

第7章 欧州の遺伝子組み換え細胞培養サプリメント市場の展望

  • 市場規模・予測
    • 金額別
  • 市場シェアと予測
    • 製品別
    • アプリケーション別
    • 再生医療別
    • バイオプロダクション別
    • エクスプレッション・システム別
    • エンドユーザー別
    • 国別
  • 欧州:国別分析
    • ドイツ
    • 英国
    • フランス
    • イタリア
    • スペイン

第8章 アジア太平洋地域の遺伝子組換え細胞培養サプリメント市場の展望

  • 市場規模・予測
    • 金額別
  • 市場シェアと予測
    • 製品別
    • アプリケーション別
    • 再生医療別
    • バイオプロダクション別
    • エクスプレッション・システム別
    • エンドユーザー別
    • 国別
  • アジア太平洋地域の:国別分析
    • 中国
    • 日本
    • 韓国
    • インド
    • オーストラリア

第9章 南米の組み換え細胞培養サプリメント市場の展望

  • 市場規模・予測
    • 金額別
  • 市場シェアと予測
    • 製品別
    • アプリケーション別
    • 再生医療別
    • バイオプロダクション別
    • エクスプレッション・システム別
    • エンドユーザー別
    • 国別
  • 南米::国別分析
    • ブラジル
    • コロンビア
    • アルゼンチン

第10章 中東・アフリカの組み換え細胞培養サプリメント市場展望

  • 市場規模・予測
    • 金額別
  • 市場シェアと予測
    • 製品別
    • アプリケーション別
    • 再生医療別
    • バイオプロダクション別
    • エクスプレッション・システム別
    • エンドユーザー別
    • 国別
  • MEA:国別分析
    • 南アフリカ組換え細胞培養用サプリメント
    • サウジアラビア組換え細胞培養用サプリメント
    • UAEリコンビナント細胞培養用サプリメント

第11章 市場力学

  • 促進要因
  • 課題すること

第12章 市場の動向と開拓

  • 最近の開発状況
  • M&A(合併・買収
  • 製品発表会

第13章 組換え細胞培養サプリメントの世界市場:SWOT分析

第14章 ポーターのファイブフォース分析

  • 業界内の競合について
  • 新規参入の可能性
  • サプライヤーの力
  • お客さまの力
  • 代替品の脅威

第15章 競合情勢

  • Abcam plc.
  • Corning Incorporated
  • BBI Solutions OEM Limited
  • FUJIFILM Irvine Scientific, Inc.
  • Gemini Bioproducts, LLC
  • HiMedia Laboratories, LLC
  • Kingfisher Biotech, Inc.
  • Lonza Group AG
  • Merck KGaA
  • Novus Biologicals, LLC
  • ThermoFisher Scientific

第16章 戦略的な提言

図表

List of Figures

  • Figure 1: Global Recombinant Cell Culture Supplements Market Size, By Value (USD Million), 2018-2028F
  • Figure 2: Global Recombinant Cell Culture Supplements Market Share, By Product, By Value, 2018-2028F
  • Figure 3: Global Recombinant Cell Culture Supplements Market Share, By Application, By Value, 2018-2028F
  • Figure 4: Global Recombinant Cell Culture Supplements Market Share, By Application, By Regenerative Medicine, By Value, 2018-2028F
  • Figure 5: Global Recombinant Cell Culture Supplements Market Share, By Application, By Bio-Production, By Value, 2018-2028F
  • Figure 6: Global Recombinant Cell Culture Supplements Market Share, By Expression System, By Value, 2018-2028F
  • Figure 7: Global Recombinant Cell Culture Supplements Market Share, By End User, By Value, 2018-2028F
  • Figure 8: Global Recombinant Cell Culture Supplements Market Share, By Region, By Value, 2018-2028F
  • Figure 9: Global Recombinant Cell Culture Supplements Market Share, By Company, By Value, 2022
  • Figure 10: Global Recombinant Cell Culture Supplements Market Map, By Product, Market Size (USD Million) & Growth Rate (%), 2022
  • Figure 11: Global Recombinant Cell Culture Supplements Market Map, By Application, Market Size (USD Million) & Growth Rate (%), 2022
  • Figure 12: Global Recombinant Cell Culture Supplements Market Map, By Application, By Regenerative Medicine, Market Size (USD Million) & Growth Rate (%), 2022
  • Figure 13: Global Recombinant Cell Culture Supplements Market Map, By Application, By Bio-Production, Market Size (USD Million) & Growth Rate (%), 2022
  • Figure 14: Global Recombinant Cell Culture Supplements Market Map, By Expression System, Market Size (USD Million) & Growth Rate (%), 2022
  • Figure 15: Global Recombinant Cell Culture Supplements Market Map, By End User, Market Size (USD Million) & Growth Rate (%), 2022
  • Figure 16: Global Recombinant Cell Culture Supplements Market Map, By Region, Market Size (USD Million) & Growth Rate (%), 2022
  • Figure 17: North America Recombinant Cell Culture Supplements Market Size, By Value (USD Million), 2018-2028F
  • Figure 18: North America Recombinant Cell Culture Supplements Market Share, By Product, By Value, 2018-2028F
  • Figure 19: North America Recombinant Cell Culture Supplements Market Share, By Application, By Value, 2018-2028F
  • Figure 20: North America Recombinant Cell Culture Supplements Market Share, By Application, By Regenerative Medicine, By Value, 2018-2028F
  • Figure 21: North America Recombinant Cell Culture Supplements Market Share, By Application, By Bio-Production, By Value, 2018-2028F
  • Figure 22: North America Recombinant Cell Culture Supplements Market Share, By Expression System, By Value, 2018-2028F
  • Figure 23: North America Recombinant Cell Culture Supplements Market Share, By End User, By Value, 2018-2028F
  • Figure 24: North America Recombinant Cell Culture Supplements Market Share, By Country, By Value, 2018-2028F
  • Figure 25: United States Recombinant Cell Culture Supplements Market Size, By Value (USD Million), 2018-2028F
  • Figure 26: United States Recombinant Cell Culture Supplements Market Share, By Product, By Value, 2018-2028F
  • Figure 27: United States Recombinant Cell Culture Supplements Market Share, By Application, By Value, 2018-2028F
  • Figure 28: United States Recombinant Cell Culture Supplements Market Share, By Expression System, By Value, 2018-2028
  • Figure 29: United States Recombinant Cell Culture Supplements Market Share, By End User, By Value, 2018-2028F
  • Figure 30: Canada Recombinant Cell Culture Supplements Market Size, By Value (USD Million), 2018-2028F
  • Figure 31: Canada Recombinant Cell Culture Supplements Market Share, By Product, By Value, 2018-2028F
  • Figure 32: Canada Recombinant Cell Culture Supplements Market Share, By Application, By Value, 2018-2028F
  • Figure 33: Canada Recombinant Cell Culture Supplements Market Share, By Expression System, By Value, 2018-2028
  • Figure 34: Canada Recombinant Cell Culture Supplements Market Share, By End User, By Value, 2018-2028F
  • Figure 35: Mexico Recombinant Cell Culture Supplements Market Size, By Value (USD Million), 2018-2028F
  • Figure 36: Mexico Recombinant Cell Culture Supplements Market Share, By Product, By Value, 2018-2028F
  • Figure 37: Mexico Recombinant Cell Culture Supplements Market Share, By Application, By Value, 2018-2028F
  • Figure 38: Mexico Recombinant Cell Culture Supplements Market Share, By Expression System, By Value, 2018-2028
  • Figure 39: Mexico Recombinant Cell Culture Supplements Market Share, By End User, By Value, 2018-2028F
  • Figure 40: Europe Recombinant Cell Culture Supplements Market Size, By Value (USD Million), 2018-2028F
  • Figure 41: Europe Recombinant Cell Culture Supplements Market Share, By Product, By Value, 2018-2028F
  • Figure 42: Europe Recombinant Cell Culture Supplements Market Share, By Application, By Value, 2018-2028F
  • Figure 43: Europe Recombinant Cell Culture Supplements Market Share, By Application, By Regenerative Medicine, By Value, 2018-2028F
  • Figure 44: Europe Recombinant Cell Culture Supplements Market Share, By Application, By Bio-Production, By Value, 2018-2028F
  • Figure 45: Europe Recombinant Cell Culture Supplements Market Share, By Expression System, By Value, 2018-2028F
  • Figure 46: Europe Recombinant Cell Culture Supplements Market Share, By End User, By Value, 2018-2028F
  • Figure 47: Europe Recombinant Cell Culture Supplements Market Share, By Country, By Value, 2018-2028F
  • Figure 48: Germany Recombinant Cell Culture Supplements Market Size, By Value (USD Million), 2018-2028F
  • Figure 49: Germany Recombinant Cell Culture Supplements Market Share, By Product, By Value, 2018-2028F
  • Figure 50: Germany Recombinant Cell Culture Supplements Market Share, By Application, By Value, 2018-2028F
  • Figure 51: Germany Recombinant Cell Culture Supplements Market Share, By Expression System, By Value, 2018-2028
  • Figure 52: Germany Recombinant Cell Culture Supplements Market Share, By End User, By Value, 2018-2028F
  • Figure 53: United Kingdom Recombinant Cell Culture Supplements Market Size, By Value (USD Million), 2018-2028F
  • Figure 54: United Kingdom Recombinant Cell Culture Supplements Market Share, By Product, By Value, 2018-2028F
  • Figure 55: United Kingdom Recombinant Cell Culture Supplements Market Share, By Application, By Value, 2018-2028F
  • Figure 56: United Kingdom Recombinant Cell Culture Supplements Market Share, By Expression System, By Value, 2018-2028
  • Figure 57: United Kingdom Recombinant Cell Culture Supplements Market Share, By End User, By Value, 2018-2028F
  • Figure 58: France Recombinant Cell Culture Supplements Market Size, By Value (USD Million), 2018-2028F
  • Figure 59: France Recombinant Cell Culture Supplements Market Share, By Product, By Value, 2018-2028F
  • Figure 60: France Recombinant Cell Culture Supplements Market Share, By Application, By Value, 2018-2028F
  • Figure 61: France Recombinant Cell Culture Supplements Market Share, By Expression System, By Value, 2018-2028
  • Figure 62: France Recombinant Cell Culture Supplements Market Share, By End User, By Value, 2018-2028F
  • Figure 63: Italy Recombinant Cell Culture Supplements Market Size, By Value (USD Million), 2018-2028F
  • Figure 64: Italy Recombinant Cell Culture Supplements Market Share, By Product, By Value, 2018-2028F
  • Figure 65: Italy Recombinant Cell Culture Supplements Market Share, By Application, By Value, 2018-2028F
  • Figure 66: Italy Recombinant Cell Culture Supplements Market Share, By Expression System, By Value, 2018-2028
  • Figure 67: Italy Recombinant Cell Culture Supplements Market Share, By End User, By Value, 2018-2028F
  • Figure 68: Spain Recombinant Cell Culture Supplements Market Size, By Value (USD Million), 2018-2028F
  • Figure 69: Spain Recombinant Cell Culture Supplements Market Share, By Product, By Value, 2018-2028F
  • Figure 70: Spain Recombinant Cell Culture Supplements Market Share, By Application, By Value, 2018-2028F
  • Figure 71: Spain Recombinant Cell Culture Supplements Market Share, By Expression System, By Value, 2018-2028
  • Figure 72: Spain Recombinant Cell Culture Supplements Market Share, By End User, By Value, 2018-2028F
  • Figure 73: Asia Pacific Recombinant Cell Culture Supplements Market Size, By Value (USD Million), 2018-2028F
  • Figure 74: Asia Pacific Recombinant Cell Culture Supplements Market Share, By Product, By Value, 2018-2028F
  • Figure 75: Asia Pacific Recombinant Cell Culture Supplements Market Share, By Application, By Value, 2018-2028F
  • Figure 76: Asia Pacific Recombinant Cell Culture Supplements Market Share, By Application, By Regenerative Medicine, By Value, 2018-2028F
  • Figure 77: Asia Pacific Recombinant Cell Culture Supplements Market Share, By Application, By Bio-Production, By Value, 2018-2028F
  • Figure 78: Asia Pacific Recombinant Cell Culture Supplements Market Share, By Expression System, By Value, 2018-2028F
  • Figure 79: Asia Pacific Recombinant Cell Culture Supplements Market Share, By End User, By Value, 2018-2028F
  • Figure 80: Asia Pacific Recombinant Cell Culture Supplements Market Share, By Country, By Value, 2018-2028F
  • Figure 81: China Recombinant Cell Culture Supplements Market Size, By Value (USD Million), 2018-2028F
  • Figure 82: China Recombinant Cell Culture Supplements Market Share, By Product, By Value, 2018-2028F
  • Figure 83: China Recombinant Cell Culture Supplements Market Share, By Application, By Value, 2018-2028F
  • Figure 84: China Recombinant Cell Culture Supplements Market Share, By Expression System, By Value, 2018-2028
  • Figure 85: China Recombinant Cell Culture Supplements Market Share, By End User, By Value, 2018-2028F
  • Figure 86: Japan Recombinant Cell Culture Supplements Market Size, By Value (USD Million), 2018-2028F
  • Figure 87: Japan Recombinant Cell Culture Supplements Market Share, By Product, By Value, 2018-2028F
  • Figure 88: Japan Recombinant Cell Culture Supplements Market Share, By Application, By Value, 2018-2028F
  • Figure 89: Japan Recombinant Cell Culture Supplements Market Share, By Expression System, By Value, 2018-2028
  • Figure 90: Japan Recombinant Cell Culture Supplements Market Share, By End User, By Value, 2018-2028F
  • Figure 91: South Korea Recombinant Cell Culture Supplements Market Size, By Value (USD Million), 2018-2028F
  • Figure 92: South Korea Recombinant Cell Culture Supplements Market Share, By Product, By Value, 2018-2028F
  • Figure 93: South Korea Recombinant Cell Culture Supplements Market Share, By Application, By Value, 2018-2028F
  • Figure 94: South Korea Recombinant Cell Culture Supplements Market Share, By Expression System, By Value, 2018-2028
  • Figure 95: South Korea Recombinant Cell Culture Supplements Market Share, By End User, By Value, 2018-2028F
  • Figure 96: India Recombinant Cell Culture Supplements Market Size, By Value (USD Million), 2018-2028F
  • Figure 97: India Recombinant Cell Culture Supplements Market Share, By Product, By Value, 2018-2028F
  • Figure 98: India Recombinant Cell Culture Supplements Market Share, By Application, By Value, 2018-2028F
  • Figure 99: India Recombinant Cell Culture Supplements Market Share, By Expression System, By Value, 2018-2028
  • Figure 100: India Recombinant Cell Culture Supplements Market Share, By End User, By Value, 2018-2028F
  • Figure 101: Australia Recombinant Cell Culture Supplements Market Size, By Value (USD Million), 2018-2028F
  • Figure 102: Australia Recombinant Cell Culture Supplements Market Share, By Product, By Value, 2018-2028F
  • Figure 103: Australia Recombinant Cell Culture Supplements Market Share, By Application, By Value, 2018-2028F
  • Figure 104: Australia Recombinant Cell Culture Supplements Market Share, By Expression System, By Value, 2018-2028
  • Figure 105: Australia Recombinant Cell Culture Supplements Market Share, By End User, By Value, 2018-2028F
  • Figure 106: South America Recombinant Cell Culture Supplements Market Size, By Value (USD Million), 2018-2028F
  • Figure 107: South America Recombinant Cell Culture Supplements Market Share, By Product, By Value, 2018-2028F
  • Figure 108: South America Recombinant Cell Culture Supplements Market Share, By Application, By Value, 2018-2028F
  • Figure 109: South America Recombinant Cell Culture Supplements Market Share, By Application, By Regenerative Medicine, By Value, 2018-2028F
  • Figure 110: South America Recombinant Cell Culture Supplements Market Share, By Application, By Bio-Production, By Value, 2018-2028F
  • Figure 111: South America Recombinant Cell Culture Supplements Market Share, By Expression System, By Value, 2018-2028F
  • Figure 112: South America Recombinant Cell Culture Supplements Market Share, By End User, By Value, 2018-2028F
  • Figure 113: South America Recombinant Cell Culture Supplements Market Share, By Country, By Value, 2018-2028F
  • Figure 114: Brazil Recombinant Cell Culture Supplements Market Size, By Value (USD Million), 2018-2028F
  • Figure 115: Brazil Recombinant Cell Culture Supplements Market Share, By Product, By Value, 2018-2028F
  • Figure 116: Brazil Recombinant Cell Culture Supplements Market Share, By Application, By Value, 2018-2028F
  • Figure 117: Brazil Recombinant Cell Culture Supplements Market Share, By Expression System, By Value, 2018-2028
  • Figure 118: Brazil Recombinant Cell Culture Supplements Market Share, By End User, By Value, 2018-2028F
  • Figure 119: Colombia Recombinant Cell Culture Supplements Market Size, By Value (USD Million), 2018-2028F
  • Figure 120: Colombia Recombinant Cell Culture Supplements Market Share, By Product, By Value, 2018-2028F
  • Figure 121: Colombia Recombinant Cell Culture Supplements Market Share, By Application, By Value, 2018-2028F
  • Figure 122: Colombia Recombinant Cell Culture Supplements Market Share, By Expression System, By Value, 2018-2028
  • Figure 123: Colombia Recombinant Cell Culture Supplements Market Share, By End User, By Value, 2018-2028F
  • Figure 124: Argentina Recombinant Cell Culture Supplements Market Size, By Value (USD Million), 2018-2028F
  • Figure 125: Argentina Recombinant Cell Culture Supplements Market Share, By Product, By Value, 2018-2028F
  • Figure 126: Argentina Recombinant Cell Culture Supplements Market Share, By Application, By Value, 2018-2028F
  • Figure 127: Argentina Recombinant Cell Culture Supplements Market Share, By Expression System, By Value, 2018-2028
  • Figure 128: Argentina Recombinant Cell Culture Supplements Market Share, By End User, By Value, 2018-2028F
  • Figure 129: Middle East & Africa Recombinant Cell Culture Supplements Market Size, By Value (USD Million), 2018-2028F
  • Figure 130: Middle East & Africa Recombinant Cell Culture Supplements Market Share, By Product, By Value, 2018-2028F
  • Figure 131: Middle East & Africa Recombinant Cell Culture Supplements Market Share, By Application, By Value, 2018-2028F
  • Figure 132: Middle East & Africa Recombinant Cell Culture Supplements Market Share, By Application, By Regenerative Medicine, By Value, 2018-2028F
  • Figure 133: Middle East & Africa Recombinant Cell Culture Supplements Market Share, By Application, By Bio-Production, By Value, 2018-2028F
  • Figure 134: Middle East & Africa Recombinant Cell Culture Supplements Market Share, By Expression System, By Value, 2018-2028F
  • Figure 135: Middle East & Africa Recombinant Cell Culture Supplements Market Share, By End User, By Value, 2018-2028F
  • Figure 136: Middle East & Africa Recombinant Cell Culture Supplements Market Share, By Country, By Value, 2018-2028F
  • Figure 137: UAE Recombinant Cell Culture Supplements Market Size, By Value (USD Million), 2018-2028F
  • Figure 138: UAE Recombinant Cell Culture Supplements Market Share, By Product, By Value, 2018-2028F
  • Figure 139: UAE Recombinant Cell Culture Supplements Market Share, By Application, By Value, 2018-2028F
  • Figure 140: UAE Recombinant Cell Culture Supplements Market Share, By Expression System, By Value, 2018-2028
  • Figure 141: UAE Recombinant Cell Culture Supplements Market Share, By End User, By Value, 2018-2028F
  • Figure 142: Saudi Arabia Recombinant Cell Culture Supplements Market Size, By Value (USD Million), 2018-2028F
  • Figure 143: Saudi Arabia Recombinant Cell Culture Supplements Market Share, By Product, By Value, 2018-2028F
  • Figure 144: Saudi Arabia Recombinant Cell Culture Supplements Market Share, By Application, By Value, 2018-2028F
  • Figure 145: Saudi Arabia Recombinant Cell Culture Supplements Market Share, By Expression System, By Value, 2018-2028
  • Figure 146: Saudi Arabia Recombinant Cell Culture Supplements Market Share, By End User, By Value, 2018-2028F
  • Figure 147: South Africa Recombinant Cell Culture Supplements Market Size, By Value (USD Million), 2018-2028F
  • Figure 148: South Africa Recombinant Cell Culture Supplements Market Share, By Product, By Value, 2018-2028F
  • Figure 149: South Africa Recombinant Cell Culture Supplements Market Share, By Application, By Value, 2018-2028F
  • Figure 150: South Africa Recombinant Cell Culture Supplements Market Share, By Expression System, By Value, 2018-2028
  • Figure 151: South Africa Recombinant Cell Culture Supplements Market Share, By End User, By Value, 2018-202
目次
Product Code: 13013

Recombinant Cell Culture Supplements Market was valued at USD 472.76 million in 2022 and is further anticipated to grow at a CAGR of 8.99% during the forecast period, owing to rising demand for biologic drugs. The recombinant cell culture supplements market is expected to continue growing in the coming years, driven by factors such as the advancements in cell culture technologies and rising investment in biopharmaceutical research.

The increasing demand for biologics has been a major driver of the recombinant cell culture supplements market. Biologic drugs are complex molecules that are produced using living cells, which are grown in culture. These drugs are increasingly being used to treat various diseases, such as cancer and autoimmune disorders. As a result, the demand for recombinant cell culture supplements has been on the rise, as they are essential for enhancing cell growth and productivity during the production of biologics.

Advancements in cell culture technologies have also contributed to the growth of the recombinant cell culture supplements market. For instance, single-use bioreactors and perfusion systems have improved cell culture processes by increasing efficiency and reducing costs. These new technologies require specialized cell culture supplements that are optimized for their use, further driving demand for recombinant cell culture supplements.

The rising prevalence of chronic diseases has contributed to the growth of the market. According to the World Health Organization (WHO), chronic diseases such as cancer, diabetes, and cardiovascular diseases are the leading causes of mortality worldwide. Biologic drugs are increasingly being used to treat these diseases, further driving the demand for recombinant cell culture supplements.

The increasing investment in biopharmaceutical research has also contributed to the growth of the market. The pharmaceutical industry is investing heavily in the research and development of new biologic drugs. This investment is driving the demand for recombinant cell culture supplements that can support the development and production of these drugs.

While the recombinant cell culture supplements market is growing rapidly, there are also several challenges that are impeding its growth. The high cost of recombinant cell culture supplements is a major challenge. These supplements are often expensive to produce, which in turn leads to higher prices for customers. This can limit the market potential for these products, particularly in emerging economies where healthcare budgets may be more constrained.

Rising Demand for Biologics Drugs

The demand for biological drugs has been rising due to their effectiveness in treating various diseases. As biological drugs are produced using living cells grown in culture, the demand for recombinant cell culture supplements has also increased. The increasing prevalence of chronic diseases, advancements in cell culture technologies, biosimilar development, and personalized medicine are all contributing to the growth of the biologics drug market, which in turn drives the demand for recombinant cell culture supplements. One of the main factors driving the growing demand for biologics is the increasing prevalence of chronic diseases. Conditions such as cancer, autoimmune disorders, and diabetes are on the rise worldwide, and traditional treatments have not been effective in managing these diseases. Biologics, however, have been shown to be highly effective in treating many of these conditions, leading to an increased demand for these drugs.

Patients are increasingly turning to biological drugs due to their perceived effectiveness and fewer side effects compared to traditional small-molecule drugs. Biologic drugs are also favored by patients who have not responded well to traditional treatments. The regulatory environment can also influence the demand for biological drugs. In recent years, regulatory agencies have placed a greater emphasis on the development and approval of biological drugs, which has increased the availability of these drugs to patients.

The growing demand for biologics has also led to increased investment in research and development. Biotech companies are constantly working to develop new biologics for a wide range of conditions, including rare diseases that previously had no effective treatments. The development of biosimilars, which are similar to existing biological drugs but produced by different manufacturers, has also increased competition and reduced the cost of these drugs. As the demand for biological drugs continues to grow, the recombinant cell culture supplements market is expected to continue to grow as well, providing opportunities for innovation and growth in the industry.

Development of Personalized Medicine

The development of personalized medicine is influencing the growth of the recombinant cell culture supplements market. Personalized medicine involves tailoring treatments to the specific needs of individual patients. This approach requires the development and production of personalized therapeutics, such as gene and cell therapies. These therapies require specialized cell culture supplements, which are used to optimize cell growth and productivity during production.

Advances in genomics, which is the study of the human genome, have enabled scientists to better understand the genetic basis of disease. This knowledge has led to the development of targeted therapies that can be customized to a patient's specific genetic profile. For example, some cancer treatments are now tailored to the specific genetic mutations of a patient's tumor, which can lead to better outcomes and fewer side effects.

As healthcare costs continue to rise, there is a growing demand for more effective and efficient healthcare. Personalized medicine approaches offer the potential for more targeted and effective treatments, which can lead to better outcomes and reduced healthcare costs in the long term. The regulatory environment can also influence the development of personalized medicine. In recent years, regulatory agencies have placed a greater emphasis on the development and approval of personalized medicine approaches, which has led to increased investment in this field.

The development of personalized medicine is also being driven by advances in technology. New diagnostic tools, such as next-generation sequencing and CRISPR gene editing, are allowing scientists to better understand the genetic basis of diseases and develop targeted therapies. In addition, advances in data analytics are enabling researchers to mine large amounts of genomic and clinical data to identify patterns and develop new treatments.

The trend toward personalized medicine is growing, which is driving the demand for recombinant cell culture supplements. As a result, the recombinant cell culture supplements market is expected to continue to grow, providing opportunities for innovation and growth in the market.

Rising Prevalence of Chronic Diseases

The rising prevalence of chronic diseases is influencing the growth of the recombinant cell culture supplements market. Chronic diseases such as cancer, diabetes, and cardiovascular diseases are the leading causes of mortality worldwide, and the demand for biological drugs to treat these diseases is increasing. Biologic drugs are produced using living cells grown in culture, which requires the use of recombinant cell culture supplements to optimize cell growth and productivity. Environmental factors such as pollution, exposure to toxins, and infectious diseases can also contribute to the development of chronic diseases. Exposure to air pollution has been linked to the development of respiratory and cardiovascular diseases, while exposure to toxins such as lead and asbestos has been linked to the development of cancer. Genetic factors can also contribute to the development of chronic diseases, with some conditions having a hereditary component. Genetic testing and personalized medicine approaches can help identify people at higher risk of developing certain chronic diseases.

The rising prevalence of chronic diseases is driving the growth of the recombinant cell culture market as more and more patients seek out innovative and effective treatments. In addition, the aging population is also contributing to the growth of this market. As people age, they are more likely to develop chronic diseases, which has led to an increased demand for new and innovative therapies.

As the prevalence of chronic diseases continues to rise, so does the demand for biological drugs and recombinant cell culture supplements. This trend is expected to continue, providing opportunities for innovation and growth in the market.

Market Segmentation

Global recombinant cell culture supplements market is segmented based on product, application, expression system, end user, and region. Based on product, the market is segmented into Recombinant Insulin, Recombinant Epidermal Growth Factors, Recombinant Albumin, Recombinant Collagen, Recombinant Transferrin, Recombinant Trypsin, and Others. Based on application, the market is further divided into Regenerative Medicine and Bio-Production. Based on regenerative medicine, the market is divided into Stem Cell Therapies, Cell Therapies, and Gene Therapies. Based on bio-production, the market is divided into Monoclonal Antibodies, Recombinant Proteins, Hormones, Vaccines, and Others. Based on the expression system, the market is segmented into Mammalian Expression System, E. coli Expression System, Yeast Expression System, and Others. Based on end users, the market is divided into Biotechnology & Pharmaceutical Companies and Academic & Research Institutions.

Market Players

Abcam plc., Corning Incorporated, BBI Solutions OEM Limited, FUJIFILM Irvine Scientific, Inc., Gemini Bioproducts, LLC, HiMedia Laboratories, LLC, Kingfisher Biotech, Inc., Lonza Group AG, Merck KGaA, Novus Biologicals, LLC, ThermoFisher Scientific, among others, are some of the key players operating in the global Recombinant Cell Culture Supplements Market.

Report Scope:

In this report, Global Recombinant Cell Culture Supplements Market has been segmented into the following categories, in addition to the industry trends, which have also been detailed below:

Recombinant Cell Culture Supplements Market, By Product:

  • Recombinant Insulin
  • Recombinant Epidermal Growth Factors
  • Recombinant Albumin
  • Recombinant Collagen
  • Recombinant Transferrin
  • Recombinant Trypsin
  • Others

Recombinant Cell Culture Supplements Market, By Application:

  • Regenerative Medicine
  • Bio-Production

Recombinant Cell Culture Supplements Market, By Regenerative Medicine:

  • Stem Cell Therapies
  • Cell Therapies
  • Gene Therapies

Recombinant Cell Culture Supplements Market, By Bio-Production:

  • Monoclonal Antibodies
  • Recombinant Proteins
  • Hormones
  • Vaccines
  • Others

Recombinant Cell Culture Supplements Market, By Expression System:

  • Mammalian Expression System
  • E. coli Expression System
  • Yeast Expression System
  • Others

Recombinant Cell Culture Supplements Market, By End User:

  • Biotechnology & Pharmaceutical Companies
  • Academic & Research Institutions

Recombinant Cell Culture Supplements Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • Germany
    • United Kingdom
    • France
    • Italy
    • Spain
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • India
    • Australia
  • South America
    • Brazil
    • Colombia
    • Argentina
  • Middle East & Africa
    • UAE
    • Saudi Arabia
    • South Africa

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the global recombinant cell culture supplements market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Recombinant Cell Culture Supplements Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Product (Recombinant Insulin, Recombinant Epidermal Growth Factors, Recombinant Albumin, Recombinant Collagen, Recombinant Transferrin, Recombinant Trypsin, Others)
    • 5.2.2. By Application (Regenerative Medicine v/s Bio-Production)
    • 5.2.3. By Regenerative Medicine (Stem Cell Therapies, Cell Therapies, Gene Therapies)
    • 5.2.4. By Bio-Production (Monoclonal Antibodies, Recombinant Proteins, Hormones, Vaccines, Others)
    • 5.2.5. By Expression System (Mammalian Expression System, E.Coli Expression System, Yeast Expression System, Others)
    • 5.2.6. By End User (Academic & Research Institutions, Biotechnology & Pharmaceutical Companies)
    • 5.2.7. By Company (2022)
    • 5.2.8. By Region
  • 5.3. Market Map
    • 5.3.1. By Product
    • 5.3.2. By Application
    • 5.3.3. By Regenerative Medicine
    • 5.3.4. By Bio-Production
    • 5.3.5. By Expression System
    • 5.3.6. By End User
    • 5.3.7. By Region

6. North America Recombinant Cell Culture Supplements Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product
    • 6.2.2. By Application
    • 6.2.3. By Regenerative Medicine
    • 6.2.4. By Bio-Production
    • 6.2.5. By Expression System
    • 6.2.6. By End User
    • 6.2.7. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Recombinant Cell Culture Supplements Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Product
        • 6.3.1.2.2. By Application
        • 6.3.1.2.3. By Expression System
        • 6.3.1.2.4. By End User
    • 6.3.2. Mexico Recombinant Cell Culture Supplements Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Product
        • 6.3.2.2.2. By Application
        • 6.3.2.2.3. By Expression System
        • 6.3.2.2.4. By End User
    • 6.3.3. Canada Recombinant Cell Culture Supplements Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Product
        • 6.3.3.2.2. By Application
        • 6.3.3.2.3. By Expression System
        • 6.3.3.2.4. By End User

7. Europe Recombinant Cell Culture Supplements Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product
    • 7.2.2. By Application
    • 7.2.3. By Regenerative Medicine
    • 7.2.4. By Bio-Production
    • 7.2.5. By Expression System
    • 7.2.6. By End User
    • 7.2.7. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Recombinant Cell Culture Supplements Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Product
        • 7.3.1.2.2. By Application
        • 7.3.1.2.3. By Expression System
        • 7.3.1.2.4. By End User
    • 7.3.2. United Kingdom Recombinant Cell Culture Supplements Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Product
        • 7.3.2.2.2. By Application
        • 7.3.2.2.3. By Expression System
        • 7.3.2.2.4. By End User
    • 7.3.3. France Recombinant Cell Culture Supplements Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Product
        • 7.3.3.2.2. By Application
        • 7.3.3.2.3. By Expression System
        • 7.3.3.2.4. By End User
    • 7.3.4. Italy Recombinant Cell Culture Supplements Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Product
        • 7.3.4.2.2. By Application
        • 7.3.4.2.3. By Expression System
        • 7.3.4.2.4. By End User
    • 7.3.5. Spain Recombinant Cell Culture Supplements Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Product
        • 7.3.5.2.2. By Application
        • 7.3.5.2.3. By Expression System
        • 7.3.5.2.4. By End User

8. Asia-Pacific Recombinant Cell Culture Supplements Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product
    • 8.2.2. By Application
    • 8.2.3. By Regenerative Medicine
    • 8.2.4. By Bio-Production
    • 8.2.5. By Expression System
    • 8.2.6. By End User
    • 8.2.7. By Country
  • 8.3. Asia-Pacific: Country Analysis
    • 8.3.1. China Recombinant Cell Culture Supplements Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Product
        • 8.3.1.2.2. By Application
        • 8.3.1.2.3. By Expression System
        • 8.3.1.2.4. By End User
    • 8.3.2. Japan Recombinant Cell Culture Supplements Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Product
        • 8.3.2.2.2. By Application
        • 8.3.2.2.3. By Expression System
        • 8.3.2.2.4. By End User
    • 8.3.3. South Korea Recombinant Cell Culture Supplements Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Product
        • 8.3.3.2.2. By Application
        • 8.3.3.2.3. By Expression System
        • 8.3.3.2.4. By End User
    • 8.3.4. India Recombinant Cell Culture Supplements Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Product
        • 8.3.4.2.2. By Application
        • 8.3.4.2.3. By Expression System
        • 8.3.4.2.4. By End User
    • 8.3.5. Australia Recombinant Cell Culture Supplements Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Product
        • 8.3.5.2.2. By Application
        • 8.3.5.2.3. By Expression System
        • 8.3.5.2.4. By End User

9. South America Recombinant Cell Culture Supplements Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product
    • 9.2.2. By Application
    • 9.2.3. By Regenerative Medicine
    • 9.2.4. By Bio-Production
    • 9.2.5. By Expression System
    • 9.2.6. By End User
    • 9.2.7. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Recombinant Cell Culture Supplements Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Product
        • 9.3.1.2.2. By Application
        • 9.3.1.2.3. By Expression System
        • 9.3.1.2.4. By End User
    • 9.3.2. Colombia Recombinant Cell Culture Supplements Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Product
        • 9.3.2.2.2. By Application
        • 9.3.2.2.3. By Expression System
        • 9.3.2.2.4. By End User
    • 9.3.3. Argentina Recombinant Cell Culture Supplements Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Product
        • 9.3.3.2.2. By Application
        • 9.3.3.2.3. By Expression System
        • 9.3.3.2.4. By End User

10. Middle East and Africa Recombinant Cell Culture Supplements Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Product
    • 10.2.2. By Application
    • 10.2.3. By Regenerative Medicine
    • 10.2.4. By Bio-Production
    • 10.2.5. By Expression System
    • 10.2.6. By End User
    • 10.2.7. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Recombinant Cell Culture Supplements Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Product
        • 10.3.1.2.2. By Application
        • 10.3.1.2.3. By Expression System
        • 10.3.1.2.4. By End User
    • 10.3.2. Saudi Arabia Recombinant Cell Culture Supplements Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Product
        • 10.3.2.2.2. By Application
        • 10.3.2.2.3. By Expression System
        • 10.3.2.2.4. By End User
    • 10.3.3. UAE Recombinant Cell Culture Supplements Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Product
        • 10.3.3.2.2. By Application
        • 10.3.3.2.3. By Expression System
        • 10.3.3.2.4. By End User

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Recent Development
  • 12.2. Mergers & Acquisitions
  • 12.3. Product Launches

13. Global Recombinant Cell Culture Supplements Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Business Overview
  • 15.2. Product Offerings
  • 15.3. Recent Developments
  • 15.4. Financials (As Reported)
  • 15.5. Key Personnel
  • 15.6. SWOT Analysis
    • 15.6.1. Abcam plc.
    • 15.6.2. Corning Incorporated
    • 15.6.3. BBI Solutions OEM Limited
    • 15.6.4. FUJIFILM Irvine Scientific, Inc.
    • 15.6.5. Gemini Bioproducts, LLC
    • 15.6.6. HiMedia Laboratories, LLC
    • 15.6.7. Kingfisher Biotech, Inc.
    • 15.6.8. Lonza Group AG
    • 15.6.9. Merck KGaA
    • 15.6.10. Novus Biologicals, LLC
    • 15.6.11. ThermoFisher Scientific

16. Strategic Recommendations